1. Home
  2. RFL vs BDL Comparison

RFL vs BDL Comparison

Compare RFL & BDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RFL
  • BDL
  • Stock Information
  • Founded
  • RFL 2017
  • BDL 1959
  • Country
  • RFL United States
  • BDL United States
  • Employees
  • RFL N/A
  • BDL N/A
  • Industry
  • RFL Real Estate
  • BDL Restaurants
  • Sector
  • RFL Finance
  • BDL Consumer Discretionary
  • Exchange
  • RFL Nasdaq
  • BDL Nasdaq
  • Market Cap
  • RFL 48.4M
  • BDL 60.8M
  • IPO Year
  • RFL N/A
  • BDL N/A
  • Fundamental
  • Price
  • RFL $1.88
  • BDL $29.00
  • Analyst Decision
  • RFL
  • BDL
  • Analyst Count
  • RFL 0
  • BDL 0
  • Target Price
  • RFL N/A
  • BDL N/A
  • AVG Volume (30 Days)
  • RFL 463.7K
  • BDL 3.3K
  • Earning Date
  • RFL 06-11-2025
  • BDL 08-12-2025
  • Dividend Yield
  • RFL N/A
  • BDL 1.54%
  • EPS Growth
  • RFL N/A
  • BDL 14.76
  • EPS
  • RFL N/A
  • BDL 2.18
  • Revenue
  • RFL $732,000.00
  • BDL $198,785,000.00
  • Revenue This Year
  • RFL N/A
  • BDL N/A
  • Revenue Next Year
  • RFL N/A
  • BDL N/A
  • P/E Ratio
  • RFL N/A
  • BDL $13.31
  • Revenue Growth
  • RFL 35.56
  • BDL 9.31
  • 52 Week Low
  • RFL $1.27
  • BDL $22.61
  • 52 Week High
  • RFL $3.19
  • BDL $35.98
  • Technical
  • Relative Strength Index (RSI)
  • RFL 54.42
  • BDL 45.79
  • Support Level
  • RFL $1.56
  • BDL $30.11
  • Resistance Level
  • RFL $1.74
  • BDL $35.18
  • Average True Range (ATR)
  • RFL 0.17
  • BDL 1.08
  • MACD
  • RFL -0.01
  • BDL -0.36
  • Stochastic Oscillator
  • RFL 49.47
  • BDL 0.00

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.

About BDL Flanigan's Enterprises Inc.

Flanigan'S Enterprises Inc operates as a chain of small cocktail lounges and packages liquor stores throughout South Florida. The business activity is principally conducted in two segments namely Restaurant and Package liquor store segment. Its Restaurant segment offers alcoholic beverages and full food service, and Package stores consist of retail liquor sales and related items. Its menu consists of a wide variety of options including prime rib, steaks, pasta, entree salads, burgers, a variety of sandwiches, and oversized signature desserts. The company generates maximum revenue from Restaurant segment.

Share on Social Networks: